DRD2 and schizophrenia: After this pharmacological characterization of dopamine receptor targets involved in the functional responses induced by dopamine, SKF38393 and NPA, and to assess the status of caudate D2R in schizophrenia, concentration–response curves for NPA were performed in membrane homogenates from 17 subjects with schizophrenia and 17 individually matched controls (Table 1).